|
|
Article: Skeletal PET with ^sup 18^F-Fluoride: Applying New Technology to an Old Tracer*
- Article from:
- The Journal of Nuclear Medicine
- Article date:
- January 1, 2008
- Author:
CopyrightCopyright Society of Nuclear Medicine Jan 2008. Provided by ProQuest LLC. (Hide copyright information)
|
Although ^sup 18^F-labeled NaF was the first widely used agent for skeletal scintigraphy, it quickly fell into disuse after the introduction of ^sup 99m^Tc-labeled bone-imaging agents. Recent comparative studies have demonstrated that ^sup 18^F-fluoride PET is more accurate than ^sup 99m^Tc-diphosphonate SPECT for identifying both malignant and benign lesions of the skeleton. Combining ^sup 18^F-fluoride PET with other imaging, such as CT, can improve the specificity and overall accuracy of skeletal ^sup 18^F-fluoride PET and probably will become the routine clinical practice for ^sup 18^F-fluoride PET. Although ^sup 18^F-labeled NaF and ^sup 99m^Tc-diphosphonate have a similar patient ...
Related newspaper, magazine, and journal articles:
|
|
Article: ^sup 68^Ga-Labeled Peptides in Tumor Imaging
The Journal of Nuclear Medicine;
January 1, 2005 ;
700+ words
... ... with positron emitters. Among these, ^sup 68^Ga deserves special attention, because ... from an in-house generator rendering ^sup 68^Ga radiopharmacy independent of an onsite cyclotron. ^sup 68^Ga has a half-life of 68 min and decays ...
|
|